The Enterprise Value as of December 2024 (TTM) for Solid Biosciences Inc. (SLDB) is 127.34M

According to Solid Biosciences Inc.’s latest financial reports and current stock price. The company's current Enterprise Value is 127.34M. This represents a change of -43.13% compared to the average of 223.90M of the last 4 quarters.

Solid Biosciences Inc. (SLDB) Historical Enterprise Value (quarterly & annually)

How has SLDB Enterprise Value performed in the past?

The mean historical Enterprise Value of Solid Biosciences Inc. over the last ten years is 303.82M. The current 127.34M Enterprise Value has changed 4.09% with respect to the historical average. Over the past ten years (40 quarters), SLDB's Enterprise Value was at its highest in in the September 2018 quarter at 1.47B. The Enterprise Value was at its lowest in in the December 2022 quarter at -83686629.30.

Solid Biosciences Inc. (SLDB) Enterprise Value by Quarter and Year

Discovering the peaks and valleys of Solid Biosciences Inc. Enterprise Value, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Solid Biosciences Inc. (SLDB) Average Enterprise Value

How has SLDB Enterprise Value performed in the past?

The current Enterprise Value of Solid Biosciences Inc. (SLDB) is greater than its 3-year, greater than its 5-year, and less than than its 10-year historical averages

Solid Biosciences Inc. (SLDB) Enterprise Value vs. Peers

How is SLDB’s Enterprise Value compared to its peers?

Solid Biosciences Inc.’s Enterprise Value is greater than Century Therapeutics, Inc. (89.16M), less than Edgewise Therapeutics, Inc. (2.76B), less than C4 Therapeutics, Inc. (280.63M), less than Mineralys Therapeutics, Inc. (539.76M), less than Cullinan Oncology, Inc. (614.81M), greater than TCR2 Therapeutics Inc. (79.12M), less than Revolution Medicines, Inc. (7.98B), greater than Black Diamond Therapeutics, Inc. (123.50M), greater than Atreca, Inc. (-8620212.00), greater than Passage Bio, Inc. (33.76M), greater than Anebulo Pharmaceuticals, Inc. (40.61M), less than Acrivon Therapeutics, Inc. Common Stock (154.58M), greater than PMV Pharmaceuticals, Inc. (40.53M), greater than Molecular Partners AG (107.67M), less than Stoke Therapeutics, Inc. (0), less than Monte Rosa Therapeutics, Inc. (451.87M), less than Cabaletta Bio, Inc. (351.25M), greater than Larimar Therapeutics, Inc. (-41011352.00), less than Alector, Inc. (211.48M), less than null (178.66M),

Build a custom stock screener for Solid Biosciences Inc. (SLDB) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Solid Biosciences Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Solid Biosciences Inc. (SLDB) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Solid Biosciences Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.